Central Nervous System Depressants: Clinical Trials

10 trials for Central Nervous System Depressants, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 unknown, 2 recruiting. 4 Not applicable, 3 Phase 4, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 4
Phase 43Completed 2, Recruiting 1
Early Phase 11Completed 1
Phase 11Completed 1

Follow Central Nervous System Depressants: new trials by email Literature Review of Central Nervous System Depressants trials Research Report on Central Nervous System Depressants

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Natural History of Depression, Bipolar Disorder and Suicide Risk
Behavioral Symptoms, Suicide
RecruitingNational Institute of Mental Health (NIMH)5002024-09-092026-10-01
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
VTS-K - Treatment Resistant Depression, Major Depressive Disorder
Phase 4CompletedTheresa Jacob, PhD, MPH152022-12-062026-04-21
Opioid-free Anesthesia in Laparoscopic Cholecystectomies
ketamine-lidocaine-dexmedetomidine, fentanyl - Pain, Postoperative, Pain, Acute
Not applicableUnknownAretaieion University Hospital702021-10-112023-02-24
Opioid-free Anesthesia With a Mixture of Dexmedetomidine-lidocaine-ketamine
ketamine-lidocaine-dexmedetomidine, fentanyl - Pain, Postoperative, Pain, Acute
Not applicableUnknownAretaieion University Hospital602021-04-012022-10-24
Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea
Drug-induced sleep endoscopy, Natural sleep endoscopy - Sleep Apnea, Obstructive, Sleep Apnea
Not applicableUnknownethisch.comite@uza.be402021-03-302021-07-26
Relative Bioavailability of LY03010 Compared to Listed Drug
LY03010; paliperidone palmitate, INVEGA SUSTENNA - Schizophrenia, Psychotic Disorders
Phase 1CompletedLuye Pharma Group Ltd.2812021-01-132023-04-25
Lidocaine and Magnesium and Ketamine in Gynecological Surgery
lidocaine-magnesium infusion, lidocaine-ketamine infusion, lidocaine infusion - Pain, Postoperative, Pain, Acute
Not applicableUnknownAretaieion University Hospital902020-11-142022-10-27
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
2% lidocaine with 1:200,000 epinephrine and epidural morphine, 3% 2-chloroprocaine and epidural morphine - Physiological Effect of Drugs, Morphine
Phase 4CompletedThe University of Texas Health Science Center, Houston442020-05-112022-05-26
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
Dexmedetomidine Hydrochloride Group - Delirium, Cognitive Dysfunction
Phase 4RecruitingSunnybrook Health Sciences Centre24002019-12-012025-12-01
Alcohol, Behavior, and Brain Imaging
Ethanol, Placebo - Alcohol Drinking, Binge Drinking
Early Phase 1CompletedUniversity of Chicago802016-01-012022-04-25

Narrower conditions

Pain, Postoperative (4)  ·  Acute Pain (3)  ·  Agnosia (3)  ·  Chronic Pain (3)  ·  Depression (2)  ·  Depressive Disorder, Major (2)  ·  Depressive Disorder, Treatment-Resistant (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neuralgia (2)  ·  Alcohol Drinking (1)  ·  Apnea (1)  ·  Behavioral Symptoms (1)  ·  Binge Drinking (1)  ·  Bipolar Disorder (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (7)  ·  Neurologic Manifestations (6)  ·  Signs and Symptoms (6)  ·  Mental Disorders (4)  ·  Nervous System Diseases (4)  ·  Pain (4)  ·  Pathologic Processes (4)  ·  Postoperative Complications (4)  ·  Behavior (3)  ·  Neurobehavioral Manifestations (3)  ·  Perceptual Disorders (3)  ·  Mood Disorders (2)  ·  Neuromuscular Diseases (2)  ·  Peripheral Nervous System Diseases (2)  ·  Alcohol-Related Disorders (1)

Interventions

Control Groups (2)  ·  Fentanyl (2)  ·  Aspirin (1)  ·  Dexmedetomidine (1)  ·  Epinephrine (1)  ·  Ethanol (1)  ·  Ketamine (1)  ·  Lidocaine (1)  ·  Paliperidone Palmitate (1)  ·  chloroprocaine (1)

Sponsors

Aretaieion University Hospital (3)  ·  Luye Pharma Group Ltd. (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Theresa Jacob, PhD, MPH (1)  ·  University of Chicago (1)  ·  ethisch.comite@uza.be (1)

Countries

United States (4)  ·  Greece (3)  ·  Belgium (1)  ·  Canada (1)

Top investigators

Elizabeth D Ballard, Ph.D. (1)  ·  Jessica Weafer (1)  ·  Kassiani Theodoraki (1)  ·  Kassiani Theodoraki, PhD, DESA (1)  ·  Kassiani Theodoraki, phD, DESA (1)  ·  Linden Lee, MD (1)  ·  Olivier Vanderveken, MD, PhD (1)  ·  Rui Li, MD (1)  ·  Stephen Choi, MD,MSc,FRCPC (1)  ·  Theresa Jacob, PhD, MPH (1)

Results publications

PMID 33201577, PMID 33849856, PMID 34950101, PMID 36534717, PMID 42752599